Q: What is Jornay PM used for?

Jornay PM is used to treat attention deficit hyperactivity disorder .

Q: How does Jornay PM work?

Mechanism of Action Jornay PM contains methylphenidate, a stimulant that affects the central nervous system. While the exact way it works to treat Attention Deficit Hyperactivity Disorder (ADHD) is not fully understood, it is believed to influence how the brain processes certain chemicals called neurotransmitters. The medication primarily targets two neurotransmitters: Dopamine: A chemical involved in motivation, reward, and movement. Norepinephrine: A chemical that affects attention and responding actions. By blocking the reabsorption of these chemicals back into the brain's nerve cells, Jornay PM increases their availability in the spaces between cells. This helps improve focus, concentration, and impulse control. Delayed-Release Technology Unlike many other ADHD medications that are taken in the morning, Jornay PM is designed to be taken in the evening. It uses a specialized two-layer coating system: The first layer delays the initial release of the drug for approximately 10 to 12 hours, allowing the patient to sleep without the stimulant effects. The second layer provides a controlled, extended release of the medication throughout the following day. This delivery method is intended to ensure the medication is active in the body when the patient wakes up and continues to work during daytime hours.

Q: What are the active ingredients in Jornay PM?

The active ingredient in Jornay PM is Methylphenidate hydrochloride .

Q: What are the side effects of Jornay PM?

Common side effects of Jornay PM may include: Decreased appetite Insomnia Nausea and others. Always consult with a healthcare professional about potential side effects.

Q: What is the dosage of Jornay PM and how do I take it?

How to Take This medication is taken by mouth once daily in the evening. It is important to take it at the same time every night, typically between 6:30 PM and 9:30 PM. Do not take this medication in the morning, as it is designed to be absorbed while you sleep and begin working when you wake up. Administration Instructions Swallowing whole: Capsules should be swallowed whole with water or another liquid. Do not crush or chew the capsules or the medicine beads inside, as this can interfere with the delayed-release timing and increase the risk of side effects. Sprinkling on food: If you have difficulty swallowing capsules, you may open the capsule and sprinkle all the beads onto a tablespoon of applesauce. Swallow the mixture immediately without chewing the beads. Do not save any of the applesauce and medicine mixture for later use. Missed Dose If you miss a dose in the evening, take it as soon as you remember that same night. If you do not remember until the following morning, skip the missed dose and take your next dose at the regular time that evening. Do not take two doses at the same time to make up for a missed one.

Q: Is Jornay PM safe during pregnancy and breastfeeding?

Pregnancy There is limited information regarding the safety of Jornay PM in pregnant individuals. Animal studies have indicated that high doses of methylphenidate may cause developmental issues, but human data is insufficient to confirm these risks. Healthcare providers generally advise using this medication during pregnancy only when the benefits to the parent are greater than the potential risks to the fetus. A pregnancy registry exists to collect information about the health of individuals who take ADHD medications during pregnancy and the health of their babies. Patients are encouraged to talk to their doctor about participating in such registries to help improve medical knowledge. Breastfeeding Methylphenidate, the active ingredient in Jornay PM, passes into breast milk in small amounts. The effects of this exposure on a nursing infant are not well-documented. If you are breastfeeding while taking this medication, it is important to monitor the infant for potential side effects, such as: Increased irritability or agitation Trouble sleeping Poor weight gain or feeding issues The decision to breastfeed while using this medication involves weighing the benefits of breastfeeding against the mother's clinical need for the drug. Consult with a healthcare provider to determine the best course of action for your specific situation.

Q: What is the FDA approval status of Jornay PM?

FDA Approval and Indications The U.S. Food and Drug Administration (FDA) approved Jornay PM for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older. It is a delayed-release and extended-release formulation of methylphenidate hydrochloride, designed to be taken in the evening to provide symptom control the following morning and throughout the day. Boxed Warning Jornay PM contains a boxed warning, which is the most serious warning required by the FDA. This warning states that CNS stimulants, including Jornay PM, have a high potential for abuse and dependence. Healthcare providers are advised to assess the risk of abuse prior to prescribing and to monitor patients for signs of misuse and dependence during treatment. Controlled Substance Status Jornay PM is classified by the Drug Enforcement Administration (DEA) as a Schedule II (CII) controlled substance. This designation is due to the medication's high potential for abuse, which may lead to severe psychological or physical dependence. Regulatory Safety Requirements As part of its regulatory status, the FDA requires that a Medication Guide be provided to patients or caregivers each time the medication is dispensed. This guide provides essential information regarding the risks of serious cardiovascular events, psychiatric adverse reactions, and the potential for growth suppression in pediatric patients.

Question 1

What is Jornay PM?

Accepted Answer

Jornay PM is an extended-release formulation of methylphenidate, which belongs to a class of medications known as central nervous system stimulants. This medication is designed with a delayed-release technology that allows it to be taken in the evening for effects that begin the following morning.

The active ingredient works by changing the levels of certain natural substances in the brain. This process helps to regulate activity in the areas of the brain responsible for attention and behavior.

Question 2

What is Jornay PM used for?

Accepted Answer

Jornay PM is used to treat attention deficit hyperactivity disorder.

Question 3

How does Jornay PM work?

Accepted Answer

Mechanism of Action

Jornay PM contains methylphenidate, a stimulant that affects the central nervous system. While the exact way it works to treat Attention Deficit Hyperactivity Disorder (ADHD) is not fully understood, it is believed to influence how the brain processes certain chemicals called neurotransmitters.

The medication primarily targets two neurotransmitters:

Dopamine: A chemical involved in motivation, reward, and movement.
Norepinephrine: A chemical that affects attention and responding actions.

By blocking the reabsorption of these chemicals back into the brain's nerve cells, Jornay PM increases their availability in the spaces between cells. This helps improve focus, concentration, and impulse control.

Delayed-Release Technology

Unlike many other ADHD medications that are taken in the morning, Jornay PM is designed to be taken in the evening. It uses a specialized two-layer coating system:

The first layer delays the initial release of the drug for approximately 10 to 12 hours, allowing the patient to sleep without the stimulant effects.
The second layer provides a controlled, extended release of the medication throughout the following day.

This delivery method is intended to ensure the medication is active in the body when the patient wakes up and continues to work during daytime hours.

Question 4

What are the active ingredients in Jornay PM?

Accepted Answer

The active ingredient in Jornay PM is Methylphenidate hydrochloride.

Question 5

What are the side effects of Jornay PM?

Accepted Answer

Common side effects of Jornay PM may include:

Decreased appetite
Insomnia
Nausea
and others.

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Jornay PM?

Accepted Answer

Jornay PM belongs to the stimulant drug class.

Question 7

What is the dosage of Jornay PM and how do I take it?

Accepted Answer

How to Take

This medication is taken by mouth once daily in the evening. It is important to take it at the same time every night, typically between 6:30 PM and 9:30 PM. Do not take this medication in the morning, as it is designed to be absorbed while you sleep and begin working when you wake up.

Administration Instructions

Swallowing whole: Capsules should be swallowed whole with water or another liquid. Do not crush or chew the capsules or the medicine beads inside, as this can interfere with the delayed-release timing and increase the risk of side effects.
Sprinkling on food: If you have difficulty swallowing capsules, you may open the capsule and sprinkle all the beads onto a tablespoon of applesauce. Swallow the mixture immediately without chewing the beads. Do not save any of the applesauce and medicine mixture for later use.

Missed Dose

If you miss a dose in the evening, take it as soon as you remember that same night. If you do not remember until the following morning, skip the missed dose and take your next dose at the regular time that evening. Do not take two doses at the same time to make up for a missed one.

Question 8

Is Jornay PM safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There is limited information regarding the safety of Jornay PM in pregnant individuals. Animal studies have indicated that high doses of methylphenidate may cause developmental issues, but human data is insufficient to confirm these risks. Healthcare providers generally advise using this medication during pregnancy only when the benefits to the parent are greater than the potential risks to the fetus.

A pregnancy registry exists to collect information about the health of individuals who take ADHD medications during pregnancy and the health of their babies. Patients are encouraged to talk to their doctor about participating in such registries to help improve medical knowledge.

Breastfeeding

Methylphenidate, the active ingredient in Jornay PM, passes into breast milk in small amounts. The effects of this exposure on a nursing infant are not well-documented. If you are breastfeeding while taking this medication, it is important to monitor the infant for potential side effects, such as:

Increased irritability or agitation
Trouble sleeping
Poor weight gain or feeding issues

The decision to breastfeed while using this medication involves weighing the benefits of breastfeeding against the mother's clinical need for the drug. Consult with a healthcare provider to determine the best course of action for your specific situation.

Question 9

What forms and strengths does Jornay PM come in?

Accepted Answer

Jornay PM is supplied as an oral extended-release capsule. The medication is contained within beads that have specialized coatings to manage the timing of the drug's release.

Administration

The capsules are typically swallowed whole.
Alternatively, the capsule may be opened and its contents sprinkled onto a spoonful of applesauce for those who cannot swallow the capsule whole.

Question 10

What is the FDA approval status of Jornay PM?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved Jornay PM for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older. It is a delayed-release and extended-release formulation of methylphenidate hydrochloride, designed to be taken in the evening to provide symptom control the following morning and throughout the day.

Boxed Warning

Jornay PM contains a boxed warning, which is the most serious warning required by the FDA. This warning states that CNS stimulants, including Jornay PM, have a high potential for abuse and dependence. Healthcare providers are advised to assess the risk of abuse prior to prescribing and to monitor patients for signs of misuse and dependence during treatment.

Controlled Substance Status

Jornay PM is classified by the Drug Enforcement Administration (DEA) as a Schedule II (CII) controlled substance. This designation is due to the medication's high potential for abuse, which may lead to severe psychological or physical dependence.

Regulatory Safety Requirements

As part of its regulatory status, the FDA requires that a Medication Guide be provided to patients or caregivers each time the medication is dispensed. This guide provides essential information regarding the risks of serious cardiovascular events, psychiatric adverse reactions, and the potential for growth suppression in pediatric patients.

Question 11

What should I know about Jornay PM and withdrawal?

Accepted Answer

Withdrawal Symptoms

If Jornay PM is stopped abruptly after regular or high-dose use, withdrawal symptoms may occur. These symptoms are often the result of the body adjusting to the absence of the stimulant medication. Common withdrawal effects include:

Extreme tiredness or fatigue
Depression or significant mood changes
Sleep problems, such as insomnia or oversleeping
Increased appetite
Irritability

Safe Discontinuation

Jornay PM is a Schedule II controlled substance, which means it carries a risk of dependence. To avoid or reduce withdrawal symptoms, healthcare providers usually recommend gradually lowering the dose rather than stopping the medication all at once. It is important to follow a doctor's specific instructions for tapering off the drug to ensure safety and monitor for any returning symptoms of ADHD.

Jornay PM

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

Found an Error?

Find Discounts for Jornay PM

Hospitals.net Disclosure